Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy

BACKGROUND: Neoadjuvant folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) and chemoradiation have been used to downstage borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC). Whether neoadjuvant therapy-induced tumor immune response contributes to the improved s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Cancer Inst
Autori principali: Michelakos, Theodoros, Cai, Lei, Villani, Vincenzo, Sabbatino, Francesco, Kontos, Filippos, Fernández-del Castillo, Carlos, Yamada, Teppei, Neyaz, Azfar, Taylor, Martin S, Deshpande, Vikram, Kurokawa, Tomohiro, Ting, David T, Qadan, Motaz, Weekes, Colin D, Allen, Jill N, Clark, Jeffrey W, Hong, Theodore S, Ryan, David P, Wo, Jennifer Y, Warshaw, Andrew L, Lillemoe, Keith D, Ferrone, Soldano, Ferrone, Cristina R
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850539/
https://ncbi.nlm.nih.gov/pubmed/32497200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa073
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi